Gender Representation in the EASL Liver Cancer Summit 2023

Assessing Progress and Challenges

Autores/as

  • Laynara Vitoria da Silva Vieira Universidade Federal do PiauI
  • Bárbara Nissara De Araújo França Universidade Federal do Piauí

DOI:

https://doi.org/10.26694/jcshuufpi.v6i2.4412

Palabras clave:

Gender equity, Representation, liver, Cancer, Congress

Resumen

Background: Women are numerically underrepresented in the field of gastroenterology and hepatology. This study aims to characterize gender representation during the EASL Liver Cancer Summit 2023. Methods: Using data available on the LCS2023 online platform, we compared the distribution of moderators, speakers, and debaters in the Plenary and Industry Sessions. Descriptive statistical analysis was conducted using R Software 4.3.0. Results: In 75% (n=18) of the sessions, women were underrepresented, comprising less than 50% of the total speakers, debaters, or moderators. Conclusion: There is a gender disparity in the oral sessions, predominantly composed and mediated by men. Additionally, the study highlighted the need to broaden the discussion and identify mechanisms for greater inclusion and retention of women in hepatology careers.

Publicado

2023-11-14

Cómo citar

da Silva Vieira, L. V., & De Araújo França, B. N. . (2023). Gender Representation in the EASL Liver Cancer Summit 2023: Assessing Progress and Challenges. Jornal De Ciências Da Saúde Do Hospital Universitário Da Universidade Federal Do Piauí, 6(2), 9–14. https://doi.org/10.26694/jcshuufpi.v6i2.4412

Número

Sección

Original

Artículos similares

También puede {advancedSearchLink} para este artículo.